Browse by topic
Subscribe to our news

“Adherence Intelligence” is the new AI

How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry research, the global pharmaceutical industry loses more than $600 billion a… Read

COVID-19: Impact on medication adherence in 2020

2020 was dominated by the COVID-19 pandemic, and it will continue to dominate healthcare conversations this year. Looking back, how did the pandemic affect medication adherence? And what lessons were learned? Patient concerns about ability to pay Back in April,… Read

DIR contracts: How to prioritize for maximum value

AllazoHealth’s William Grambley, Chief Operating Officer, and Dr. Linda Schultz, VP, Clinical and Customer Success, address the factors that pharmacies should consider when prioritizing their DIR contracts. Their discussion includes how to evaluate thresholds and population attribution, and how AI… Read

Patient intervention data for pharma, payers and pharmacies: FAQ

AllazoHealth CEO Clifford Jones and Chief Operating Officer William Grambley recently answered questions about patient intervention data: what it is, how clients employ it, and how AllazoHealth uses this data to accurately predict individual patient behavior. Is using patient intervention… Read

Two recent studies show smart pill bottles have positive impact

Small study demonstrates smart pill bottles can improve adherence interventions for cancer patients A smart pill bottle platform improved adherence and patient satisfaction among a small sample of multiple myeloma patients, according to a paper in the November 2019 issue… Read

How is the Pharmaceutical Industry Addressing Medication Adherence?

Medication non-adherence continues to be one of the most widespread issues faced by the pharmaceutical industry. According to the U.S. Centers for Disease Control, approximately 50 percent of people with chronic illnesses stop taking their medications within one year of… Read

Artificial intelligence: What it is and what it’s not

There are a lot of companies that claim they offer solutions that are powered by artificial intelligence (AI) and/or machine learning. But what exactly does that mean? AI and machine learning Artificial intelligence is a system that learns. It acquires… Read

Four tips for a successful adherence program

For payers and pharmacists, designing an effective adherence program to support patients can be challenging, according to AllazoHealth’s William Grambley, COO, and Dr. Linda Schultz, VP, Clinical and Customer Success. Keeping these tips in mind can help. Design your program… Read

4 ways to improve pharmacy inventory management

About 3% of the 3.6 billion prescriptions written annually are abandoned at the pharmacy, according to Power-Pak C.E. And US Pharmacist reports that inventory represents the single largest investment and ongoing expense for most pharmacies, so managing it well has… Read

Special report: behavioral marketing trends for pharma brands

Produced by MM+M and sponsored by AllazoHealth, this free special report offers a deep dive into how recent innovations in behavioral marketing and economics empower pharma marketers. You’ll learn about how behavioral insights shape strategy and messaging to spur both… Read

Election 2020: The impact on medication adherence

This year’s election could have a major effect on adherence rates. Here are some possible changes in healthcare policy that could be enacted under Trump or Biden, and the impact on adherence. Revocation of the ACA In November, the Supreme… Read

Stay Connected

Subscribe to our emails for updates on trending topics, best practices, and advancements in healthcare and AI.